News
-
Visit Macro & Micro-Test at MEDICA 2026 – Hall 3, Booth H72-3
Macro & Micro-Test welcomes you to visit us at MEDICA 2026, Hall 3, Booth H72-3, to discover how our molecular diagnostic platforms and reagents can support your diagnostic workflows. At our booth, we will showcase two core platforms: Eudemon™ AIO800 Automated Molecular Diagnostic System An ...Read more -
Respiratory Infection Season in the Northern Hemisphere: Why Tiered Testing Matters
As influenza, RSV, SARS-CoV-2, adenovirus, and other respiratory pathogens co-circulate, healthcare providers face a common challenge: How can pathogen evidence be obtained early enough to guide clinical decisions? For hospitalized and critically ill patients, broader pathogen and antimicrobial r...Read more -
Antimicrobial Resistance: The Importance of Timely Detection
—Insights from the ACORN-HAI Study and Macro & Micro-Test’s Carbapenem Resistance Detection Solutions Antimicrobial resistance (AMR) remains a major challenge in healthcare, particularly for patients with severe hospital-acquired infections. When commonly used antibiotics become less ef...Read more -
From Rapid Screening to Molecular Answers: Building a Flexible Respiratory Testing Strategy
A patient has a fever, cough, or sore throat. At home, they may want a quick answer. At a pharmacy or primary care setting, the priority may be rapid assessment and triage. In a hospital, clinicians may need to know exactly which pathogen is involved. Same symptoms. Different questions. Different...Read more -
From Rapid Screening to Molecular Answers: Building a Flexible Respiratory Testing Strategy
A patient has a fever, cough, or sore throat. At home, they may want a quick answer. At a pharmacy or primary care setting, the priority may be rapid assessment and triage. In a hospital, clinicians may need to know exactly which pathogen is involved. Same symptoms. Different questions. Different...Read more -
Rising Measles Cases Highlight the Urgent Need for Early Diagnosis and Genomic Surveillance
From early clinical recognition to laboratory confirmation and genomic analysis, strengthening measles surveillance is essential in an era of renewed outbreaks and cross-border transmission. Measles remains one of the most contagious vaccine-preventable diseases. Despite progress toward eliminati...Read more -
One Sample. 14 Respiratory Pathogens. A Broader View of Infection.
Cough, fever, sore throat, fatigue, and shortness of breath are common symptoms of respiratory infections. But similar symptoms can be caused by very different pathogens — from influenza viruses and RSV to adenovirus, rhinovirus/enterovirus, Mycoplasma pneumoniae, Chlamydia pneumoniae, and Bordet...Read more -
Why Flu Negative Test Isn’t the End of the Respiratory Testing Question
One flu negative result can answer one question. It may not explain the illness. A patient presents with fever, cough and sore throat. The influenza test is negative. What does that actually tell us? It tells us that influenza was not detected by that particular test. It does not tell us which re...Read more -
Getting Ready for the European Respiratory Season: Why Flexible Testing Matters
As Europe moves into the autumn and winter months, respiratory virus surveillance and testing preparedness become increasingly important. Influenza, respiratory syncytial virus (RSV), and SARS-CoV-2 continue to contribute to the burden of acute respiratory infections across Europe, while the circ...Read more -
Helicobacter Pylori Detection: From Screening to Eradication Confirmation
Nearly Half the World’s Population May Be Infected. But H. pylori Testing Is More Than a Single Test. In 1982, Barry Marshall and Robin Warren identified and cultured Helicobacter pylori from gastric biopsy specimens, fundamentally changing our understanding of peptic ulcer disease. Their discove...Read more -
One Test, 32 Targets: Rethinking Fungal Molecular Detection During Fungal Disease Awareness Week
From Pathogen Identification to a Broader Molecular Picture Fungal infections can be difficult to diagnose. Clinical manifestations are often nonspecific, while conventional culture may require time to provide actionable microbiological information. In critically ill or immunocompromised patients...Read more -
From Langya to Wetland to ALTNV: Macro & Micro-Test’s Emerging Pathogen Discovery Toolkit Supports a Third NEJM Publication
On September 3, 2026, The New England Journal of Medicine (NEJM) published a correspondence reporting the discovery of Asian longhorned tick nairovirus (ALTNV), a novel tick-borne orthonairovirus identified by a research team from the State Key Laboratory of Pathogen and Biosecurity, Beijing. Th...Read more